Amway (China) R&D Center
7
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
The Efficacy of Nutrilite All-plant Protein Booster to Improve Sarcopenia and Osteoarthritis in Middle-aged and Elderly People
Role: lead
Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index
Role: lead
Improvement and Safety of Nutrilite Protein MetX Pro on Weight Management in Overweight Individuals With Dyslipidemia
Role: lead
To Investigate Effects of Amway Bundle Combination of Products on Osteoarthritis & Sarcopenia
Role: lead
The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia
Role: lead
The Efficacy of Amway Herbal Drink to Improve Skin Anti-aging
Role: lead
Nutrilite Memory Builder on the Improvement of Cognitive Function
Role: lead
All 7 trials loaded